Funding for this research was provided by:
Innovative Medicines Initiative (115736)
Received: 15 April 2020
Accepted: 1 October 2020
First Online: 15 October 2020
Ethics approval and consent to participate
: All participants provided informed consent to join the EPAD LCS and ethical approval was obtained from ethics committees local to each study site. The establishment of participant panels formed part of the ethics submission in each country. No additional written consent was taken to join the participant panels.
: Not applicable.
: The authors declare that they have no competing interests.